{"entity":{"type":"insider","cik":"0001507650","url":"/insider/0001507650","json_url":"/insider/0001507650.json","name":"Zanganeh Mahkam","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":59,"n_filings":25,"first":"2013-12-18","last":"2026-06-12","span_basis":"filed_date"},"name_variants":[{"name":"Zanganeh Mahkam","source":"filing","n_filings":8,"first_seen":"2023-03-08","last_seen":"2026-06-12"},{"name":"Zanganeh Maky","source":"filing","n_filings":17,"first_seen":"2013-12-18","last_seen":"2022-08-18"}],"transactions":[{"id":6130400,"accession":"0001507650-26-000007","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001507650-26-000007","line_url":"/filing/0001507650-26-000007#line-1","is_derivative":false,"issuer_cik":"0001507650","issuer_name":"Summit Therapeutics Inc.","issuer_ticker":"SMMT","issuer_name_source":null,"issuer_url":"/issuer/0001507650","owner_cik":"0001507650","owner_name":"Zanganeh Mahkam","owner_display_name":"Zanganeh Mahkam","owner_url":"/insider/0001507650","role":"Director, Officer (Co-Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Co-Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3810000.0,"shares_display":"3,810,000","price_per_share":13.12,"price_display":"13.12","price_state":"stated","total_value":49987200.0,"total_display":"49,987,200.00","total_whole":"49,987,200","shares_owned_after":573883879.0,"shares_owned_after_display":"573,883,879","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-12","filed_date":"2026-06-12","scope":"insider"},{"id":5981098,"accession":"0001507650-26-000005","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001507650-26-000005","line_url":"/filing/0001507650-26-000005#line-1","is_derivative":false,"issuer_cik":"0001507650","issuer_name":"Summit Therapeutics Inc.","issuer_ticker":"SMMT","issuer_name_source":null,"issuer_url":"/issuer/0001507650","owner_cik":"0001507650","owner_name":"Zanganeh Mahkam","owner_display_name":"Zanganeh Mahkam","owner_url":"/insider/0001507650","role":"Director, Officer (Co-Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Co-Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":14.6,"price_display":"14.60","price_state":"stated","total_value":1460000.0,"total_display":"1,460,000.00","total_whole":"1,460,000","shares_owned_after":25824474.0,"shares_owned_after_display":"25,824,474","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-04","filed_date":"2026-06-04","scope":"insider"},{"id":4783402,"accession":"0001507650-25-000003","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001507650-25-000003","line_url":"/filing/0001507650-25-000003#line-3","is_derivative":false,"issuer_cik":"0001507650","issuer_name":"Summit Therapeutics Inc.","issuer_ticker":"SMMT","issuer_name_source":null,"issuer_url":"/issuer/0001507650","owner_cik":"0001507650","owner_name":"Zanganeh Mahkam","owner_display_name":"Zanganeh Mahkam","owner_url":"/insider/0001507650","role":"Director, Officer (Co-Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Co-Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":26680.0,"shares_display":"26,680","price_per_share":18.74,"price_display":"18.74","price_state":"stated","total_value":499983.2,"total_display":"499,983.20","total_whole":"499,983","shares_owned_after":76680.0,"shares_owned_after_display":"76,680","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-10-21","filed_date":"2025-10-23","scope":"insider"},{"id":4867092,"accession":"0001599298-25-000143","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001599298-25-000143","line_url":"/filing/0001599298-25-000143#line-2","is_derivative":false,"issuer_cik":"0001507650","issuer_name":"Summit Therapeutics Inc.","issuer_ticker":"SMMT","issuer_name_source":null,"issuer_url":"/issuer/0001507650","owner_cik":"0001507650","owner_name":"Zanganeh Mahkam","owner_display_name":"Zanganeh Mahkam","owner_url":"/insider/0001507650","role":"Director, Officer (Co-Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Co-Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":18.07,"price_display":"18.07","price_state":"stated","total_value":90350.0,"total_display":"90,350.00","total_whole":"90,350","shares_owned_after":556093090.0,"shares_owned_after_display":"556,093,090","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-11","filed_date":"2025-09-11","scope":"insider"},{"id":4867086,"accession":"0001599298-25-000143","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001599298-25-000143","line_url":"/filing/0001599298-25-000143#line-1","is_derivative":false,"issuer_cik":"0001507650","issuer_name":"Summit Therapeutics Inc.","issuer_ticker":"SMMT","issuer_name_source":null,"issuer_url":"/issuer/0001507650","owner_cik":"0001507650","owner_name":"Zanganeh Mahkam","owner_display_name":"Zanganeh Mahkam","owner_url":"/insider/0001507650","role":"Director, Officer (Co-Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Co-Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":333394.0,"shares_display":"333,394","price_per_share":17.68,"price_display":"17.68","price_state":"stated","total_value":5894405.92,"total_display":"5,894,405.92","total_whole":"5,894,406","shares_owned_after":556088090.0,"shares_owned_after_display":"556,088,090","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-10","filed_date":"2025-09-11","scope":"insider"},{"id":2290509,"accession":"0001599298-24-000047","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001599298-24-000047","line_url":"/filing/0001599298-24-000047","is_derivative":false,"issuer_cik":"0001507650","issuer_name":"Summit Therapeutics Inc.","issuer_ticker":"SMMT","issuer_name_source":null,"issuer_url":"/issuer/0001507650","owner_cik":"0001507650","owner_name":"Zanganeh Mahkam","owner_display_name":"Zanganeh Mahkam","owner_url":"/insider/0001507650","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":80321.0,"shares_display":"80,321","price_per_share":3.7175099911604685,"price_display":"3.72","price_state":"stated","total_value":298594.12,"total_display":"298,594.12","total_whole":"298,594","shares_owned_after":24923800.0,"shares_owned_after_display":"24,923,800","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-03-27","filed_date":"2024-03-27","scope":"insider","n_lines":3},{"id":2290499,"accession":"0001599298-24-000047","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001599298-24-000047","line_url":"/filing/0001599298-24-000047#line-1","is_derivative":false,"issuer_cik":"0001507650","issuer_name":"Summit Therapeutics Inc.","issuer_ticker":"SMMT","issuer_name_source":null,"issuer_url":"/issuer/0001507650","owner_cik":"0001507650","owner_name":"Zanganeh Mahkam","owner_display_name":"Zanganeh Mahkam","owner_url":"/insider/0001507650","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":3.75,"price_display":"3.75","price_state":"stated","total_value":112500.0,"total_display":"112,500.00","total_whole":"112,500","shares_owned_after":30000.0,"shares_owned_after_display":"30,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-03-26","filed_date":"2024-03-27","scope":"insider"},{"id":7880687,"accession":"0001599298-23-000103","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001599298-23-000103","line_url":"/filing/0001599298-23-000103#line-3","is_derivative":false,"issuer_cik":"0001507650","issuer_name":"Summit Therapeutics Inc.","issuer_ticker":"SMMT","issuer_name_source":null,"issuer_url":"/issuer/0001507650","owner_cik":"0001507650","owner_name":"Zanganeh Mahkam","owner_display_name":"Zanganeh Mahkam","owner_url":"/insider/0001507650","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":2.07,"price_display":"2.07","price_state":"stated","total_value":10350.0,"total_display":"10,350.00","total_whole":"10,350","shares_owned_after":494814.0,"shares_owned_after_display":"494,814","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-12","filed_date":"2023-12-13","scope":"insider"},{"id":9285908,"accession":"0001387131-23-003381","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001387131-23-003381","line_url":"/filing/0001387131-23-003381","is_derivative":false,"issuer_cik":"0001507650","issuer_name":"Summit Therapeutics Inc.","issuer_ticker":"SMMT","issuer_name_source":null,"issuer_url":"/issuer/0001507650","owner_cik":"0001507650","owner_name":"Zanganeh Mahkam","owner_display_name":"Zanganeh Mahkam","owner_url":"/insider/0001507650","role":"Director, Officer (Co-CEO & President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Co-CEO & President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":23527044.0,"shares_display":"23,527,044","price_per_share":1.05,"price_display":"1.05","price_state":"stated","total_value":24703396.2,"total_display":"24,703,396.20","total_whole":"24,703,396","shares_owned_after":9884095.0,"shares_owned_after_display":"9,884,095","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-03-08","filed_date":"2023-03-13","scope":"insider","n_lines":2},{"id":8211585,"accession":"0001599298-23-000028","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001599298-23-000028","line_url":"/filing/0001599298-23-000028","is_derivative":false,"issuer_cik":"0001507650","issuer_name":"Summit Therapeutics Inc.","issuer_ticker":"SMMT","issuer_name_source":null,"issuer_url":"/issuer/0001507650","owner_cik":"0001507650","owner_name":"Zanganeh Mahkam","owner_display_name":"Zanganeh Mahkam","owner_url":"/insider/0001507650","role":"Director, Officer (Co-Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Co-Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":23527044.0,"shares_display":"23,527,044","price_per_share":1.05,"price_display":"1.05","price_state":"stated","total_value":24703396.2,"total_display":"24,703,396.20","total_whole":"24,703,396","shares_owned_after":23395269.0,"shares_owned_after_display":"23,395,269","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-08","filed_date":"2023-03-08","scope":"insider","n_lines":3},{"id":6363130,"accession":"0001387131-22-008886","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001387131-22-008886","line_url":"/filing/0001387131-22-008886","is_derivative":false,"issuer_cik":"0001507650","issuer_name":"Summit Therapeutics Inc.","issuer_ticker":"SMMT","issuer_name_source":null,"issuer_url":"/issuer/0001507650","owner_cik":"0001507650","owner_name":"Zanganeh Maky","owner_display_name":"Zanganeh Maky","owner_url":"/insider/0001507650","role":"Director, Officer (Co-CEO & President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Co-CEO & President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5809132.0,"shares_display":"5,809,132","price_per_share":0.97,"price_display":"0.97","price_state":"stated","total_value":5634858.04,"total_display":"5,634,858.04","total_whole":"5,634,858","shares_owned_after":7061557.0,"shares_owned_after_display":"7,061,557","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-08-16","filed_date":"2022-08-18","scope":"insider","n_lines":3},{"id":4828181,"accession":"0000921895-21-001334","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000921895-21-001334","line_url":"/filing/0000921895-21-001334#line-1","is_derivative":false,"issuer_cik":"0001507650","issuer_name":"Summit Therapeutics Inc.","issuer_ticker":"SMMT","issuer_name_source":null,"issuer_url":"/issuer/0001507650","owner_cik":"0001507650","owner_name":"Zanganeh Maky","owner_display_name":"Zanganeh Maky","owner_url":"/insider/0001507650","role":"Director, Officer (Chief Operating Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":389077.0,"shares_display":"389,077","price_per_share":5.24,"price_display":"5.24","price_state":"stated","total_value":2038763.48,"total_display":"2,038,763.48","total_whole":"2,038,763","shares_owned_after":2643319.0,"shares_owned_after_display":"2,643,319","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-05-12","filed_date":"2021-05-14","scope":"insider"},{"id":2470881,"accession":"0001209191-20-038948","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-038948","line_url":"/filing/0001209191-20-038948#line-1","is_derivative":false,"issuer_cik":"0001507650","issuer_name":"Pulse Biosciences, Inc.","issuer_ticker":"PLSE","issuer_name_source":null,"issuer_url":"/issuer/0001507650","owner_cik":"0001507650","owner_name":"Zanganeh Maky","owner_display_name":"Zanganeh Maky","owner_url":"/insider/0001507650","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1193.0,"shares_display":"1,193","price_per_share":10.7017,"price_display":"10.70","price_state":"stated","total_value":12767.1281,"total_display":"12,767.13","total_whole":"12,767","shares_owned_after":106767.0,"shares_owned_after_display":"106,767","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-06-23","filed_date":"2020-06-25","scope":"insider"},{"id":2544924,"accession":"0001209191-20-037928","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-037928","line_url":"/filing/0001209191-20-037928#line-1","is_derivative":false,"issuer_cik":"0001507650","issuer_name":"Pulse Biosciences, Inc.","issuer_ticker":"PLSE","issuer_name_source":null,"issuer_url":"/issuer/0001507650","owner_cik":"0001507650","owner_name":"Zanganeh Maky","owner_display_name":"Zanganeh Maky","owner_url":"/insider/0001507650","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7950.0,"shares_display":"7,950","price_per_share":7.01,"price_display":"7.01","price_state":"stated","total_value":55729.5,"total_display":"55,729.50","total_whole":"55,730","shares_owned_after":105574.0,"shares_owned_after_display":"105,574","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-06-17","filed_date":"2020-06-19","scope":"insider"},{"id":4786655,"accession":"0001209191-17-065914","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-065914","line_url":"/filing/0001209191-17-065914#line-1","is_derivative":false,"issuer_cik":"0001507650","issuer_name":"Pulse Biosciences, Inc.","issuer_ticker":"PLSE","issuer_name_source":null,"issuer_url":"/issuer/0001507650","owner_cik":"0001507650","owner_name":"Zanganeh Maky","owner_display_name":"Zanganeh Maky","owner_url":"/insider/0001507650","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1100.0,"shares_display":"1,100","price_per_share":23.98,"price_display":"23.98","price_state":"stated","total_value":26378.0,"total_display":"26,378.00","total_whole":"26,378","shares_owned_after":95574.0,"shares_owned_after_display":"95,574","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-12-13","filed_date":"2017-12-15","scope":"insider"},{"id":5183242,"accession":"0001209191-17-065525","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-065525","line_url":"/filing/0001209191-17-065525#line-2","is_derivative":false,"issuer_cik":"0001507650","issuer_name":"Pulse Biosciences, Inc.","issuer_ticker":"PLSE","issuer_name_source":null,"issuer_url":"/issuer/0001507650","owner_cik":"0001507650","owner_name":"Zanganeh Maky","owner_display_name":"Zanganeh Maky","owner_url":"/insider/0001507650","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":23.979,"price_display":"23.98","price_state":"stated","total_value":23979.0,"total_display":"23,979.00","total_whole":"23,979","shares_owned_after":94474.0,"shares_owned_after_display":"94,474","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-12-12","filed_date":"2017-12-13","scope":"insider"},{"id":5183237,"accession":"0001209191-17-065525","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-065525","line_url":"/filing/0001209191-17-065525#line-1","is_derivative":false,"issuer_cik":"0001507650","issuer_name":"Pulse Biosciences, Inc.","issuer_ticker":"PLSE","issuer_name_source":null,"issuer_url":"/issuer/0001507650","owner_cik":"0001507650","owner_name":"Zanganeh Maky","owner_display_name":"Zanganeh Maky","owner_url":"/insider/0001507650","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":22.763,"price_display":"22.76","price_state":"stated","total_value":68289.0,"total_display":"68,289.00","total_whole":"68,289","shares_owned_after":93474.0,"shares_owned_after_display":"93,474","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-12-11","filed_date":"2017-12-13","scope":"insider"},{"id":5210036,"accession":"0001209191-17-053234","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-17-053234","line_url":"/filing/0001209191-17-053234#line-3","is_derivative":false,"issuer_cik":"0001507650","issuer_name":"Pulse Biosciences, Inc.","issuer_ticker":"PLSE","issuer_name_source":null,"issuer_url":"/issuer/0001507650","owner_cik":"0001507650","owner_name":"Zanganeh Maky","owner_display_name":"Zanganeh Maky","owner_url":"/insider/0001507650","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7775.0,"shares_display":"7,775","price_per_share":15.0213,"price_display":"15.02","price_state":"stated","total_value":116790.6075,"total_display":"116,790.61","total_whole":"116,791","shares_owned_after":332500.0,"shares_owned_after_display":"332,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-18","filed_date":"2017-09-18","scope":"insider"},{"id":5210032,"accession":"0001209191-17-053234","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-053234","line_url":"/filing/0001209191-17-053234","is_derivative":false,"issuer_cik":"0001507650","issuer_name":"Pulse Biosciences, Inc.","issuer_ticker":"PLSE","issuer_name_source":null,"issuer_url":"/issuer/0001507650","owner_cik":"0001507650","owner_name":"Zanganeh Maky","owner_display_name":"Zanganeh Maky","owner_url":"/insider/0001507650","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":22000.0,"shares_display":"22,000","price_per_share":12.767240909090908,"price_display":"12.77","price_state":"stated","total_value":280879.3,"total_display":"280,879.30","total_whole":"280,879","shares_owned_after":315725.0,"shares_owned_after_display":"315,725","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-14","filed_date":"2017-09-18","scope":"insider","n_lines":2},{"id":5281729,"accession":"0001209191-17-047762","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-17-047762","line_url":"/filing/0001209191-17-047762","is_derivative":false,"issuer_cik":"0001507650","issuer_name":"Pulse Biosciences, Inc.","issuer_ticker":"PLSE","issuer_name_source":null,"issuer_url":"/issuer/0001507650","owner_cik":"0001507650","owner_name":"Zanganeh Maky","owner_display_name":"Zanganeh Maky","owner_url":"/insider/0001507650","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20500.0,"shares_display":"20,500","price_per_share":23.47960975609756,"price_display":"23.48","price_state":"stated","total_value":481332.0,"total_display":"481,332.00","total_whole":"481,332","shares_owned_after":302725.0,"shares_owned_after_display":"302,725","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-03","filed_date":"2017-08-04","scope":"insider","n_lines":3},{"id":5281719,"accession":"0001209191-17-047762","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-047762","line_url":"/filing/0001209191-17-047762#line-1","is_derivative":false,"issuer_cik":"0001507650","issuer_name":"Pulse Biosciences, Inc.","issuer_ticker":"PLSE","issuer_name_source":null,"issuer_url":"/issuer/0001507650","owner_cik":"0001507650","owner_name":"Zanganeh Maky","owner_display_name":"Zanganeh Maky","owner_url":"/insider/0001507650","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8290.0,"shares_display":"8,290","price_per_share":25.147,"price_display":"25.15","price_state":"stated","total_value":208468.63,"total_display":"208,468.63","total_whole":"208,469","shares_owned_after":287225.0,"shares_owned_after_display":"287,225","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-02","filed_date":"2017-08-04","scope":"insider"},{"id":4563310,"accession":"0001209191-17-031672","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-17-031672","line_url":"/filing/0001209191-17-031672#line-3","is_derivative":false,"issuer_cik":"0001507650","issuer_name":"Pulse Biosciences, Inc.","issuer_ticker":"PLSE","issuer_name_source":null,"issuer_url":"/issuer/0001507650","owner_cik":"0001507650","owner_name":"Zanganeh Maky","owner_display_name":"Zanganeh Maky","owner_url":"/insider/0001507650","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":20.836,"price_display":"20.84","price_state":"stated","total_value":312540.0,"total_display":"312,540.00","total_whole":"312,540","shares_owned_after":278935.0,"shares_owned_after_display":"278,935","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-11","filed_date":"2017-05-11","scope":"insider"},{"id":4563307,"accession":"0001209191-17-031672","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-031672","line_url":"/filing/0001209191-17-031672#line-2","is_derivative":false,"issuer_cik":"0001507650","issuer_name":"Pulse Biosciences, Inc.","issuer_ticker":"PLSE","issuer_name_source":null,"issuer_url":"/issuer/0001507650","owner_cik":"0001507650","owner_name":"Zanganeh Maky","owner_display_name":"Zanganeh Maky","owner_url":"/insider/0001507650","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":21.709,"price_display":"21.71","price_state":"stated","total_value":108545.0,"total_display":"108,545.00","total_whole":"108,545","shares_owned_after":85474.0,"shares_owned_after_display":"85,474","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-05-10","filed_date":"2017-05-11","scope":"insider"},{"id":4563300,"accession":"0001209191-17-031672","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-031672","line_url":"/filing/0001209191-17-031672#line-1","is_derivative":false,"issuer_cik":"0001507650","issuer_name":"Pulse Biosciences, Inc.","issuer_ticker":"PLSE","issuer_name_source":null,"issuer_url":"/issuer/0001507650","owner_cik":"0001507650","owner_name":"Zanganeh Maky","owner_display_name":"Zanganeh Maky","owner_url":"/insider/0001507650","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":33760.0,"shares_display":"33,760","price_per_share":20.157,"price_display":"20.16","price_state":"stated","total_value":680500.32,"total_display":"680,500.32","total_whole":"680,500","shares_owned_after":80474.0,"shares_owned_after_display":"80,474","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-05-09","filed_date":"2017-05-11","scope":"insider"},{"id":6797545,"accession":"0001209191-18-021891","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-18-021891","line_url":"/filing/0001209191-18-021891","is_derivative":false,"issuer_cik":"0001507650","issuer_name":"Pulse Biosciences, Inc.","issuer_ticker":"PLSE","issuer_name_source":null,"issuer_url":"/issuer/0001507650","owner_cik":"0001507650","owner_name":"Zanganeh Maky","owner_display_name":"Zanganeh Maky","owner_url":"/insider/0001507650","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":22.373333333333335,"price_display":"22.37","price_state":"stated","total_value":67120.0,"total_display":"67,120.00","total_whole":"67,120","shares_owned_after":27000.0,"shares_owned_after_display":"27,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-03-20","filed_date":"2018-03-28","scope":"insider","n_lines":2},{"id":4196155,"accession":"0001209191-17-021889","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-17-021889","line_url":"/filing/0001209191-17-021889","is_derivative":false,"issuer_cik":"0001507650","issuer_name":"Pulse Biosciences, Inc.","issuer_ticker":"PLSE","issuer_name_source":null,"issuer_url":"/issuer/0001507650","owner_cik":"0001507650","owner_name":"Zanganeh Maky","owner_display_name":"Zanganeh Maky","owner_url":"/insider/0001507650","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9280.0,"shares_display":"9,280","price_per_share":22.70098275862069,"price_display":"22.70","price_state":"stated","total_value":210665.12,"total_display":"210,665.12","total_whole":"210,665","shares_owned_after":263935.0,"shares_owned_after_display":"263,935","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-20","filed_date":"2017-03-20","scope":"insider","n_lines":3},{"id":6797539,"accession":"0001209191-18-021891","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-18-021891","line_url":"/filing/0001209191-18-021891#line-5","is_derivative":false,"issuer_cik":"0001507650","issuer_name":"Pulse Biosciences, Inc.","issuer_ticker":"PLSE","issuer_name_source":null,"issuer_url":"/issuer/0001507650","owner_cik":"0001507650","owner_name":"Zanganeh Maky","owner_display_name":"Zanganeh Maky","owner_url":"/insider/0001507650","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":23.93,"price_display":"23.93","price_state":"stated","total_value":47860.0,"total_display":"47,860.00","total_whole":"47,860","shares_owned_after":25000.0,"shares_owned_after_display":"25,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-03-17","filed_date":"2018-03-28","scope":"insider"},{"id":4196145,"accession":"0001209191-17-021889","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-021889","line_url":"/filing/0001209191-17-021889#line-1","is_derivative":false,"issuer_cik":"0001507650","issuer_name":"Pulse Biosciences, Inc.","issuer_ticker":"PLSE","issuer_name_source":null,"issuer_url":"/issuer/0001507650","owner_cik":"0001507650","owner_name":"Zanganeh Maky","owner_display_name":"Zanganeh Maky","owner_url":"/insider/0001507650","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8960.0,"shares_display":"8,960","price_per_share":23.996,"price_display":"24.00","price_state":"stated","total_value":215004.16,"total_display":"215,004.16","total_whole":"215,004","shares_owned_after":42434.0,"shares_owned_after_display":"42,434","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-03-17","filed_date":"2017-03-20","scope":"insider"},{"id":6797536,"accession":"0001209191-18-021891","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-18-021891","line_url":"/filing/0001209191-18-021891#line-4","is_derivative":false,"issuer_cik":"0001507650","issuer_name":"Pulse Biosciences, Inc.","issuer_ticker":"PLSE","issuer_name_source":null,"issuer_url":"/issuer/0001507650","owner_cik":"0001507650","owner_name":"Zanganeh Maky","owner_display_name":"Zanganeh Maky","owner_url":"/insider/0001507650","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6200.0,"shares_display":"6,200","price_per_share":12.152,"price_display":"12.15","price_state":"stated","total_value":75342.4,"total_display":"75,342.40","total_whole":"75,342","shares_owned_after":13000.0,"shares_owned_after_display":"13,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-02-15","filed_date":"2018-03-28","scope":"insider"},{"id":4650621,"accession":"0001209191-17-013103","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-013103","line_url":"/filing/0001209191-17-013103#line-1","is_derivative":false,"issuer_cik":"0001507650","issuer_name":"Pulse Biosciences, Inc.","issuer_ticker":"PLSE","issuer_name_source":null,"issuer_url":"/issuer/0001507650","owner_cik":"0001507650","owner_name":"Zanganeh Maky","owner_display_name":"Zanganeh Maky","owner_url":"/insider/0001507650","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":13000.0,"shares_display":"13,000","price_per_share":11.973,"price_display":"11.97","price_state":"stated","total_value":155649.0,"total_display":"155,649.00","total_whole":"155,649","shares_owned_after":33474.0,"shares_owned_after_display":"33,474","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-02-15","filed_date":"2017-02-22","scope":"insider"},{"id":6797535,"accession":"0001209191-18-021891","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-021891","line_url":"/filing/0001209191-18-021891#line-3","is_derivative":false,"issuer_cik":"0001507650","issuer_name":"Pulse Biosciences, Inc.","issuer_ticker":"PLSE","issuer_name_source":null,"issuer_url":"/issuer/0001507650","owner_cik":"0001507650","owner_name":"Zanganeh Maky","owner_display_name":"Zanganeh Maky","owner_url":"/insider/0001507650","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9500.0,"shares_display":"9,500","price_per_share":12.119,"price_display":"12.12","price_state":"stated","total_value":115130.5,"total_display":"115,130.50","total_whole":"115,131","shares_owned_after":23000.0,"shares_owned_after_display":"23,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-02-14","filed_date":"2018-03-28","scope":"insider"},{"id":6797531,"accession":"0001209191-18-021891","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-021891","line_url":"/filing/0001209191-18-021891","is_derivative":false,"issuer_cik":"0001507650","issuer_name":"Pulse Biosciences, Inc.","issuer_ticker":"PLSE","issuer_name_source":null,"issuer_url":"/issuer/0001507650","owner_cik":"0001507650","owner_name":"Zanganeh Maky","owner_display_name":"Zanganeh Maky","owner_url":"/insider/0001507650","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":11.155333333333333,"price_display":"11.16","price_state":"stated","total_value":33466.0,"total_display":"33,466.00","total_whole":"33,466","shares_owned_after":13500.0,"shares_owned_after_display":"13,500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-02-13","filed_date":"2018-03-28","scope":"insider","n_lines":2},{"id":9269522,"accession":"0001209191-15-026712","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-026712","line_url":"/filing/0001209191-15-026712#line-1","is_derivative":false,"issuer_cik":"0000949699","issuer_name":"PHARMACYCLICS INC","issuer_ticker":"PCYC","issuer_name_source":null,"issuer_url":"/issuer/0000949699","owner_cik":"0001507650","owner_name":"Zanganeh Maky","owner_display_name":"Zanganeh Maky","owner_url":"/insider/0001507650","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":254.1148,"price_display":"254.11","price_state":"stated","total_value":7623444.0,"total_display":"7,623,444.00","total_whole":"7,623,444","shares_owned_after":225312.0,"shares_owned_after_display":"225,312","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-11","filed_date":"2015-03-16","scope":"insider"},{"id":8338874,"accession":"0001209191-15-026168","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-026168","line_url":"/filing/0001209191-15-026168#line-2","is_derivative":false,"issuer_cik":"0000949699","issuer_name":"PHARMACYCLICS INC","issuer_ticker":"PCYC","issuer_name_source":null,"issuer_url":"/issuer/0000949699","owner_cik":"0001507650","owner_name":"Zanganeh Maky","owner_display_name":"Zanganeh Maky","owner_url":"/insider/0001507650","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":254.1148,"price_display":"254.11","price_state":"stated","total_value":7623444.0,"total_display":"7,623,444.00","total_whole":"7,623,444","shares_owned_after":225312.0,"shares_owned_after_display":"225,312","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-11","filed_date":"2015-03-13","scope":"insider"},{"id":6206204,"accession":"0001209191-14-068222","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001209191-14-068222","line_url":"/filing/0001209191-14-068222","is_derivative":false,"issuer_cik":"0000949699","issuer_name":"PHARMACYCLICS INC","issuer_ticker":"PCYC","issuer_name_source":null,"issuer_url":"/issuer/0000949699","owner_cik":"0001507650","owner_name":"Zanganeh Maky","owner_display_name":"Zanganeh Maky","owner_url":"/insider/0001507650","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5931.0,"shares_display":"5,931","price_per_share":137.95581977744055,"price_display":"137.96","price_state":"stated","total_value":818215.9671,"total_display":"818,215.97","total_whole":"818,216","shares_owned_after":210970.0,"shares_owned_after_display":"210,970","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-12","filed_date":"2014-11-12","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":"2014-11-12|6206200","ledger_fault":false,"count":{"value":59,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":46,"open_market":true},{"code":"S","label":"Open-market sale","n":13,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":59},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001599298","name":"Summit Therapeutics Inc.","url":"/issuer/0001599298","role":"Director, Officer (Co-Chief Executive Officer), Ten percent owner","n_filings":10,"first_seen":"2021-05-14","last_seen":"2026-06-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001625101","name":"Pulse Biosciences, Inc.","url":"/issuer/0001625101","role":"Director","n_filings":10,"first_seen":"2017-02-22","last_seen":"2020-06-25"},{"type":"issuer","type_label":"ISSUER","cik":"0000949699","name":"PHARMACYCLICS INC","url":"/issuer/0000949699","role":"Officer (Chief Operating Officer)","n_filings":5,"first_seen":"2013-12-18","last_seen":"2015-03-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001507650","retrieved_at":"2026-08-25T22:06:10+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}